期刊文献+

胰岛素抵抗与肾癌的相关性研究

下载PDF
导出
摘要 目的:探讨胰岛素抵抗与肾癌发病的相关性。方法:选择健康男性50例、肾癌患者50例,分别抽取静脉血检测空腹血清胰岛素(FINS)、空腹血糖(FBG),计算胰岛素抵抗指数(IRI)、胰岛分泌指数(HOMA-β)、胰岛素敏感指数(ISI)。比较两组检测结果及计算指标的差异。结果:对照组和肾癌组空腹血糖比较无统计学差异(P>0.05),但FINS、IRI及ISI肾癌组较对照组明显升高(P<0.05);肾癌组不同分期FINS、IRI及ISI比较无统计学差异(P>0.05)。结论:胰岛素抵抗与肾癌发病相关。
出处 《中国民族民间医药》 2015年第23期62-63,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
  • 相关文献

参考文献7

  • 1熊婷,邱少红,余蓉.利用HOMA指数评价胰岛素抵抗及β细胞分泌胰岛素功能[J].湖北中医杂志,2012,34(10):16-17. 被引量:19
  • 2KimYI. Diet, lifestyle, and colorctal cancer: is typerinsulinemia the missinglink [J]. Nutr Rev, 1998, 56 (9): 275 - 279.
  • 3Spyridopoulos TN, Dessypris N, Antoniadis AG, et al. Insulin resistanceand risk of renal cell cancer: a csae - control study [ J]. Hormones (Athens),2012,11 (3): 308-315.
  • 4Yoshikawa T, Noguchi Y. Contributions of tumor types and stages on insulinresistance in patients with cancer : precliminary report [ J ]. Nihon Geka GakkaiZasshi, 1995, 96 (8): 586.
  • 5Bulut S,Aktas BK, Erkmen AE, et al. Metabolic syndrome prevalence inrenal cell cancer patients [J]. Asian Pac J Cancer Prev, 2014, 15 (18): 7925-7928.
  • 6吕炳建,来茂德.代谢综合征、胰岛素抵抗与结直肠癌[J].中华病理学杂志,2006,35(2):110-112. 被引量:10
  • 7Bulut S,Aktas BK, Erkmen AE, et al. Metabolic syndrome prevalence in re-nal cell cancer patients [ J]. Asian Pac J Cancer Prev, 2014, 15 (18): 7925-7928.

二级参考文献39

  • 1李霞,周智广,亓海英,陈小燕,黄干.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能[J].中南大学学报(医学版),2004,29(4):419-423. 被引量:214
  • 2卢艳慧,陆菊明.空腹血糖受损与糖耐量减低的概念及表现谱的差异和对策[J].国际内分泌代谢杂志,2006,26(1):5-8. 被引量:17
  • 3Giovannucci E,Colditz GA,Stampfer MJ,et al.Physical activity,obesity and risk ofcolorectal adenoma in women (United States).Cancer Causes Control,1996,7:253-263.
  • 4Limburg PJ,Anderson KE,Johnson TW,et al.Diabetes mellitus and subsite-specificcolorectal cancer risks in the Iowa Women′s Health Study.Cancer Epidemiol BiomarkersPrev,2005,14:133-137.
  • 5McKeown-Essen G.Epidemiology of colorectal cancer revised:are serum triglyceridesand/or plasma glucose assocaited with risk? Cancer Epidemiol BiomarkerPrev,1994,3:687-695.
  • 6Giovannucci E.Insulin and colon cancer.Cancer Causes Control,1995,6:164-179.
  • 7Sandhu MS,Dunger DB,Giovannucci EL.Insulin,insulin-like growth factor-I (IGF-I),IGFbinding proteins,their biologic interactions,and colorectal cancer.J Natl CancerInst,2002,94:972-980.
  • 8White MF.Insulin signaling in health and disease.Science,2003,302:1710-1711.
  • 9Brownlee M.Biochemistry and molecular cell biology of diabeticcomplications.Nature,2003,414:813-820.
  • 10Hirose Y,Hata K,Kuno T,et al.Enhancement of development of azoxymethane-inducedcolonic premalignant lesions in C56BL/KsJ-db/db mice.Carcinogenesis,2004,25:821-825.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部